Efficacy News and Research

RSS

Study reports increased numbers of SARS-CoV-2-reactive T cells in individuals who were HCoV-reactive

T cell responses were measured to three SARS-CoV-2-associated antigens, as well as the endemic coronaviruses HCoV-OC43 and HCoV-NL63.

25 Apr 2022

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

As part of World Malaria Day 2022, we interview Karine Le Roch PH.D., about her latest research into how novel antimalarial therapeutic strategies could be on the horizon, after identifying two proteins that are critical to the survival of the malaria parasite, Plasmodium falciparum.

25 Apr 2022

Anti-SARS-CoV-2 spike antibody levels following COVID-19 BNT162b2 vaccination

Researchers assessed factors influencing the anti-severe acute respiratory syndrome coronavirus 2 spike antibodies after SARS-CoV-2 BNT162b2 vaccination.

25 Apr 2022

Vaccine effectiveness against symptomatic disease caused by the Omicron and Delta variants in England

The researchers aimed to estimate how effective vaccination was against severe COVID-19, caused by Omicron and Delta variants of the virus, in England.

25 Apr 2022

The challenges of Omicron

A new review published in sums up the position of Omicron as a potential threat to human health, especially in the context of controlling this pandemic.

25 Apr 2022

The long-term impact of prior SARS-CoV-2 infection on immune responses after COVID-19 vaccination

The study aimed to determine the impact of prior infection from SARS-CoV-2 infection on immune responses after COVID-19 vaccination in the long term.

25 Apr 2022

World Immunization Week 2022: Striving for a Long Life for All with the International Vaccine Institute

As part of World Immunization Week 2022, News Medical speaks to the International Vaccine Institute about their fight against vaccine inequity, as well as what a “Long Life for All” means to them.

25 Apr 2022

Monoclonal-antibody combination AZD7442 prevents COVID-19

In a recent study published in The New England Journal of Medicine, the researchers examined the monoclonal-antibody combination AZD7442 to prevent coronavirus disease 2019 (COVID-19).

25 Apr 2022

Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

A recent review paper, published in the MDPI’s specialized journal COVID, highlights key features of the Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – and examines the potential and roadblocks in using renewable marine resources in the fight against the coronavirus disease 2019 (COVID-19).

24 Apr 2022

Impact of COVID-19 vaccination on anti-nucleocapsid antibody levels

Anti-N antibodies may have lower sensitivity in mRNA-1273-vaccinated individuals who were previously infected with SARS-CoV-2.

24 Apr 2022

Heterologous booster dose leads to better SARS-CoV-2 vaccine performance, study shows

A new study on Chile's national COVID-19 vaccination program, to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon 23-26), and published in The Lancet Global Health, shows that giving a different type of vaccine (heterologous) for the third or 'booster' dose than was received for the first two doses, leads to better vaccine performance than using the same (homologous) inactivated SARS-CoV-2 vaccine for all three doses.

24 Apr 2022

Study demonstrates increased incidence of SARS-CoV-2 Omicron breakthrough infection in cancer patients

Scientists have demonstrated the incidence of SARS-CoV-2 infection in cancer patients residing in Austria and Italy.

22 Apr 2022

Efficacy of vaccination against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages in Sweden

Researchers compared the vaccine effectiveness against infections by SARS-CoV-2 variant of concern Omicron BA.1 and BA.2 sublineages in Sweden.

22 Apr 2022

Interleukin-6 levels predict early withdrawal of COVID-19 patients from mechanical ventilation

Researchers reported that plasma IL-6 levels in patients with ARDS due to COVID-19 could predict early withdrawal from mechanical ventilation.

22 Apr 2022

Booster dose of BNT162b2 mRNA vaccine induces a high cross-neutralizing response against SARS-CoV-2 variants

Researchers assessed the impact of SARS-CoV-2 mRNA booster vaccine on the SARS-CoV-2 Omicron variant.

22 Apr 2022

COVID-19 mRNA vaccine protects against ICU admission for 1 year

Researchers investigate the duration of effectiveness of mRNA-based COVID-19 vaccines in preventing ICU admission.

21 Apr 2022

Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

Researchers isolate three mAbs that broadly neutralized sarbecoviruses and carried out virological and structural studies of these mAbs.

21 Apr 2022

Hybrid alphavirus-SARS-CoV-2 pseudovirus system rapidly measures neutralizing antibodies

Do a person's antibodies work to block the COVID-19 virus from infecting one's system? Are these antibodies also capable of blocking emerging variants such as the omicrons?

21 Apr 2022

Antibody-based treatment, endogenous immune responses, and within-host SARS-CoV-2 evolution in immunocompromised patients

Researchers investigated the interplay of all the factors responsible for within-host evolution of SARS-CoV-2 variants in immunocompromised patients.

21 Apr 2022

Evolution of SARS-CoV-2 variants

Research has demonstrated the evolutionary process and biology of SARS-CoV-2, the causative pathogen of the COVID-19 pandemic.

21 Apr 2022

Efficacy News and Research

Study reports increased numbers of SARS-CoV-2-reactive T cells in individuals who were HCoV-reactive

World Malaria Day 2022: How the knockdown of P. falciparum RAP01 and RAP21 proteins could lead to novel antimalarial therapeutics

Anti-SARS-CoV-2 spike antibody levels following COVID-19 BNT162b2 vaccination

Vaccine effectiveness against symptomatic disease caused by the Omicron and Delta variants in England

The challenges of Omicron

The long-term impact of prior SARS-CoV-2 infection on immune responses after COVID-19 vaccination

World Immunization Week 2022: Striving for a Long Life for All with the International Vaccine Institute

Monoclonal-antibody combination AZD7442 prevents COVID-19

Marine resources could be promising drug candidates against SARS-CoV-2 Omicron

Impact of COVID-19 vaccination on anti-nucleocapsid antibody levels

Heterologous booster dose leads to better SARS-CoV-2 vaccine performance, study shows

Study demonstrates increased incidence of SARS-CoV-2 Omicron breakthrough infection in cancer patients

Efficacy of vaccination against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages in Sweden

Interleukin-6 levels predict early withdrawal of COVID-19 patients from mechanical ventilation

Booster dose of BNT162b2 mRNA vaccine induces a high cross-neutralizing response against SARS-CoV-2 variants

COVID-19 mRNA vaccine protects against ICU admission for 1 year

Antibodies that neutralize most sarbecoviruses, including SARS-CoV-2 variants

Hybrid alphavirus-SARS-CoV-2 pseudovirus system rapidly measures neutralizing antibodies

Antibody-based treatment, endogenous immune responses, and within-host SARS-CoV-2 evolution in immunocompromised patients

Evolution of SARS-CoV-2 variants

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News